Dr. Kermani’s research interests include molecular and cellular mechanisms of lung injury, inflammation, asthma, pulmonary and other types of fibrosis; regulation of cytokine, chemokine and cell signaling in inflammation, fibrosis and cancer, the roles of urokinase and matrix metalloproteinases in fibrosis, asthma and lung cancer; the role of urokinase in lung inflammation and immune response to pathogens and how cytokines and chemokines mediate those responses. She has published more than 50 papers in this area. Dr. Kermani research efforts are focused on elucidating the molecular pathways through which CXC-type chemokines promote tissue fibrosis and cancer and how these processes are modulated by obesity and type 2 diabetes mellitus. Her current research has focused on functional genomic, bioinformatics and molecular approaches to study fibrosis and cancer for the purposes of understanding fibrosis and cancer biology as well as discovery of biomarkers. Since 1998 she served as the course director and taught N541 Physiology and N544 Pathophysiology courses and lecturers in Pathology 580/630 for dental and biomedical sciences students at the University of Michigan Medical and Dental Schools. In addition, since 2013 she served as the course director and taught Medical Virology at the University of Massachusetts, Boston. She also has served as Editorial Board member, Peer Reviewer and Referee for several American and European journals.
